WGS Form 4: CFO tax sell-to-cover and RSU settlement
Rhea-AI Filing Summary
GeneDx Holdings (WGS) CFO reported routine equity activity. On 10/29/2025, 753 restricted stock units settled into Class A shares at $0, and 388 shares were sold at $136.54 to cover tax withholding tied to the RSU vesting.
After these transactions, the reporting person beneficially owned 3,757 Class A shares. They also held RSUs representing up to 123,880 shares and options to purchase up to 25,906 shares, which vest according to their terms.
The RSU vesting schedule states 25% vested on April 29, 2023 and April 29, 2024, with an additional 6.25% vesting each quarterly anniversary thereafter, with the final tranche scheduled for April 29, 2026.
Positive
- None.
Negative
- None.
Insights
Routine Form 4: RSU vesting and tax sell-to-cover.
The filing records RSU settlement into 753 common shares on 10/29/2025 and a sale of 388 shares at $136.54 to satisfy tax withholding. This is a standard administrative step linked to equity compensation.
Post-transaction holdings show 3,757 shares beneficially owned, plus RSUs for up to 123,880 shares and options for up to 25,906 shares. The vesting cadence (25% on April 29, 2023 and 2024, then 6.25% quarterly through April 29, 2026) governs future share delivery.
This activity does not signal a discretionary sale beyond tax obligations. Any future impact depends on continued service and vesting under the stated schedule.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 753 | $0.00 | -- |
| Exercise | Class A Common Stock | 753 | $0.00 | -- |
| Sale | Class A Common Stock | 388 | $136.54 | $53K |
Footnotes (1)
- Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 3,757 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 123,880 shares of Class A Common Stock and options to purchase up to an aggregate of 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms. 25% of the total award vested on each of April 29, 2023 and April 29, 2024, and an additional 6.25% of the total award vested or vests thereafter on each quarterly anniversary, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the last tranche scheduled to vest on April 29, 2026. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.
